YAMAMOTO HIROFUMI has a total of 19 patent applications. It increased the IP activity by 300.0%. Its first patent ever was published in 2002. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and computer technology are ALTIMMUNE INC, SUN JIEGUANG and AMPLIPHI BIOSCIENCES CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Japan | 2 | |
#5 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Computer technology | |
#4 | Textiles and paper | |
#5 | Telecommunications | |
#6 | Digital networks | |
#7 | Optics |
# | Name | Total Patents |
---|---|---|
#1 | Yamamoto Hirofumi | 19 |
#2 | Mori Masaki | 12 |
#3 | Doki Yuichiro | 7 |
#4 | Wu Xin | 3 |
#5 | Akaike Toshihiro | 2 |
#6 | Nakanishi Hiroyuki | 2 |
#7 | Akazawa Kiyoshi | 1 |
#8 | Fukasawa Kazuhiko | 1 |
#9 | Taguchi Shinichirou | 1 |
#10 | Kisumino Takashi | 1 |
Publication | Filing date | Title |
---|---|---|
WO2018199121A1 | Prophylactic or therapeutic agent for inflammatory bowel disease | |
WO2018030338A1 | Adjuvant composition | |
US2017073675A1 | RNA sequence having anti-tumour activity | |
JP2014105197A | Super apatite ultrafine nanoparticle | |
US2010169624A1 | Adaptive fetch advance control for a low power processor | |
JP2004199163A | Method and system for sharing commuter |